[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":129710.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":277529753.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-276000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-855983.0,"NetIncomeLoss_1_Q2_USD":-16864623.0,"NetIncomeLoss_2_Q2_USD":-43275879.0,"NonoperatingIncomeExpense_1_Q2_USD":-16066297.0,"NonoperatingIncomeExpense_2_Q2_USD":-42419934.0,"OperatingCostsAndExpenses_1_Q2_USD":798326.0,"OperatingCostsAndExpenses_2_Q2_USD":855945.0,"OperatingIncomeLoss_1_Q2_USD":-798326.0,"OperatingIncomeLoss_2_Q2_USD":-855945.0,"OtherUnderwritingExpense_2_Q2_USD":495247.0,"PaymentsToAcquireInvestments_2_Q2_USD":276000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"PreferredStockSharesIssued_0_Q2_shares":null,"PreferredStockSharesOutstanding_0_Q2_shares":null,"PreferredStockValue_0_Q2_USD":null,"PrepaidExpenseCurrent_0_Q2_USD":128610.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":270480000.0,"ProceedsFromIssuanceOfPrivatePlacement_2_Q2_USD":7520000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-43277017.0,"SharePrice_0_Q2_USD":10.0,"StockholdersEquity_0_Q2_USD":5000002.0,"StockRedeemedOrCalledDuringPeriodValue_1_Q2_USD":16864623.0,"LiabilitiesCurrent_0_Q2_USD":129710.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":276811833.0,"Liabilities_0_Q2_USD":68121554.0,"InvestmentIncomeNonoperating_2_Q2_USD":504743.0,"AdditionalPaidInCapital_0_Q2_USD":48275606.0,"Assets_0_Q2_USD":276811833.0,"AssetsCurrent_0_Q2_USD":802380.0,"AssetsFairValueDisclosure_0_Q2_USD":28498177.0,"AssetsHeldInTrustCurrent_0_Q2_USD":276009453.0,"AssetsHeldInTrustNoncurrent_0_Q2_USD":276009453.0,"Capital_0_Q2_USD":25000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":673770.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":673770.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":1.5,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":166666.0,"CommitmentsAndContingencies_0_Q2_USD":null,"TemporaryEquityRedemptionPricePerShare_0_Q2_USD":18.0,"CommonStockSharesOutstanding_0_Q2_shares":7230972.0,"DeferredOfferingCosts_0_Q2_USD":null,"DerivativeLiabilities_0_Q2_USD":58331844.0,"ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_2_Q2_USD":5520000.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":16073179.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":41924644.0,"FederalDepositInsuranceCorporationPremiumExpense_2_Q2_USD":250000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":128572.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":128610.0,"InterestAndDebtExpense_2_Q2_USD":100000.0,"InterestIncomeOther_1_Q2_USD":6882.0,"InterestIncomeOther_2_Q2_USD":9453.0,"InvestmentIncomeInterest_2_Q2_USD":9453.0,"CommonStockValue_0_Q2_USD":690.0,"UnsecuredDebt_0_Q2_USD":300000.0,"Ticker":"SLGC","CIK":"1837412","name":"CM LIFE SCIENCES II INC.","OfficialName":"SomaLogic Inc. Class A Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1247459487.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20210816"}]